Worth a closer look
- Open-market purchase with their own money (Form 4 code P), not a grant or option exercise.
- Raised their own holding by 882%.
- Similar past buys beat the S&P 500 52% of the time (268 cases), above the 46% for all buys.
Reasons for caution
- None found in the data.
What happened after this filing
Insider Twins: past buys with the same traits
1 insider buying · no CEO or CFO · $250K–$1M · stock down 20%+ in 3 months
ICHR Nov 17, 2025 +224.6% vs S&PKLXE Mar 11, 2020 +152.2% vs S&PCSPI Dec 15, 2023 +130.2% vs S&PAVTX Apr 24, 2023 -100.3% vs S&PCTNT Jun 17, 2026 -98.6% vs S&PRUBI Jun 16, 2026 -87.1% vs S&PWhat we couldn't check
- Why they traded. Filings don't say, and we don't guess.
- Company news after the filing, and any private terms.
D Christian Koch (a director) bought $986K of XYL at about $89.60 on Oct 29, 2026, reported to the SEC on Oct 29, 2026. Buys like this beat the S&P 500 52% of the time since 2020, against 46% for all insider buys. We found 3 points that make it worth a closer look and 0 reasons for caution. History, not a prediction.
Following. We'll keep this page updated; see everything you follow. Want an email when the 30 and 90-day results land? Use the XYL alerts below.
Written by fixed rules from SEC filings and our measured history, not by an AI model. Public data only. History, not a prediction, and not investment advice.